Contract Research Organization Services Market Size, Growth, Share & Trends Analysis
Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global contract research organization (CRO) services market is expected to reach USD 125.95 billion in 2030 from USD 84.61 billion in 2025, at a CAGR of 8.3% during the forecast period. Factors such as the increasing complexity & the growing volume of trials; the rising focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs are supporting the growth of this market.
KEY TAKEAWAYS
-
BY REGIONNorth America is the largest market, accounting for a share of 44.9% in 2024. The region is home to several prominent CROs. Additionally, the region presence of a well-established pharmaceutical industry, a large number of ongoing clinical trial studies and growing R&D expenditure in the region.
-
BY SERVICE TYPEClinical research services contributed largest share of 57.3% in 2024. This is because Phase I to IV trial execution of clinical trials are the most resource-intensive and cost-driving stage of drug development.
-
BY THERAPEUTIC AREAOncology dominates the market with 35.4% share in 2024. It remains the most innovation-intensive area in drug development, with pipelines expanding and clinical development productivity improving, fueling sustained trial demand.
-
BY END USERBy end user, the Medical device companies end user is expected to grow at the fastest rate during the forecast period of 2025 to 2030.
-
COMPETITIVE LANDSCAPEMajor market players have adopted both organic and inorganic strategies, including partnerships and investments. Thermo Fisher Scientific Inc. launched the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need for real-world, adolescent-specific evidence and data related to this autoimmune disease.
The CRO services market is witnessing steady growth, driven by factors such as the increasing complexity & the growing volume of trials; the rising focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs are supporting the growth of this market. Moreover, the upcoming therapeutic drugs patent cliff is fueling pharmaceutical companies to invest heavily in R&D activities and outsource their clinical trials to CROs. Additionally, the growing regulatory focus on patient diversity and data analysis offerings favoring customer reimbursement & market access strategy are other key growth opportunities.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The impact on biopharma clients’ businesses in the CRO services market arises from evolving sponsor demands and changes in global R&D strategy. Pharmaceutical, biotechnology, medical device, and diagnostics companies are the largest users of CRO solutions, with efficient clinical development and regulatory compliance as primary focus areas. Trends such as increased outsourcing, adoption of decentralized and digital clinical trials, and stricter regulatory requirements now directly affect project timelines, budgets, and commercial launch success for sponsors.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing volume of trials and subsequent rise in complexities.

-
Growing focus on decentralized/patient centric trials
Level
-
No restraints
Level
-
Increasing regulatory focus on clinical trial diversification
-
Growing adoption of risk-based monitoring
Level
-
Patient retention
-
Cybersecurity and intellectual property challenges
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing volume of trials and subsequent rise in complexities.
The steady rise in global clinical trial volume and increasing protocol complexity are key drivers of CRO market growth. More trials target niche populations in oncology, rare diseases, and cell & gene therapies, requiring specialized expertise and broader geographic reach. Protocol designs demand larger datasets, adaptive methodologies, biomarker integration, and real-world evidence collection, significantly expanding operational demands. These complexities push sponsors to outsource to CROs that can provide global site networks, advanced data analytics, and regulatory alignment. By alleviating the resource and infrastructure burden for sponsors, CROs are positioned as essential partners in accelerating trial execution and ensuring compliance across multiple geographies. As pipelines expand and therapeutic science evolves, the reliance on CRO services is expected to deepen, reinforcing their central role in modern drug development.
Restraint: -
-
Opportunity: Increasing regulatory focus on clinical trial diversification.
Regulatory agencies like the FDA and EMA are increasing requirements for diversity in clinical trials to ensure effective treatments for all populations. The FDA’s 2024 guidelines require trial sponsors to develop Diversity Action Plans (DAPs) to include underrepresented groups, while the EMA’s Clinical Trials Regulation (EU) No. 536/2014 promotes broader participant inclusion. In Europe, the UK HRA/MHRA is piloting Inclusion & Diversity Plans for clinical trials, widening the opportunity for CRO partners with community outreach, decentralized models, and real-world data to deliver on these plans across geographies. In response, CROs are enhancing their offerings, thereby establishing an opportunity for growth during the forecast period.
Challenge: Patient retention.
Patient retention remains a consistent challenge mainly due to burdensome visit schedules, complex protocols, and long study durations. These can derail endpoints. Thus, CROs are building patient-centric programs explicitly to boost engagement and keep participants enrolled. For instance, IQVIA is tackling attrition with digital and in-home support. Its Health Research Space patient app earned a 2025 MedTech Breakthrough Award for engagement, and its Decentralized Trial Suite added Mobile Research Nursing & Phlebotomy to bring visits to the patient, reducing the friction that drives dropouts.
contract-research-organization-service-market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
ICON plc provided clinical trial services to the Pfizer and BioNTech SE investigational COVID-19 vaccine programme. | Provided high level of remote clinical monitoring and source data verification, safeguarding data quality and integrity in the evolving pandemic environment |
|
|
IQVIA collaborated with Janssen Research & Development, LLC on the Phase 3 COVID-19 vaccine clinical trials | The client leveraged IQVIA's suite of decentralised trial solutions. Employment of telehealth technologies, virtual oversight, and digital patient engagement strategies |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The CRO services market ecosystem comprises contract research organizations (such as IQVIA, ICON, Syneos Health), specialized service providers (for clinical trials, data management, regulatory affairs), and sponsor clients including pharmaceutical, biotechnology, and medical device companies (like Pfizer, Novartis, and Medtronic). CROs provide essential expertise and infrastructure to design, execute, and manage clinical studies, advancing new therapies from early discovery through regulatory approval. Sponsors rely on CRO partners for cost efficiency, faster timelines, and access to global patient populations, while CROs deliver operational excellence and regulatory compliance. Collaborative partnerships across this value chain are essential for accelerating innovation, lowering development costs, and ensuring success in a highly regulated, competitive life sciences market.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
CRO Services Market, By Service Type
As of 2024, clinical research services held the largest share of the CRO services market and will continue leading the market through 2025. The large share of this segment is attributed to the Phase I to IV trial execution of clinical trials being the most resource-intensive and cost-driving stage of drug development. Sponsors increasingly rely on CROs for clinical monitoring, site management, patient recruitment, medical writing, pharmacovigilance, and trial operations to accelerate timelines and meet regulatory demands.
CRO Services Market, By Modality
In 2024, small molecules modality dominated the market The large share of this market can be attributed to factors such as the dominance of the pipeline in terms of volume and the loss of exclusivity of patented products. Additionally, the generics and bioequivalence market adds recurring study volume.
CRO Services Market, By Therapeutic area
In 2024, the oncology therapeutic area is expected to dominate the CRO Services market. Oncology commands the largest share of CRO services because it remains the most innovation-intensive area in drug development, with pipelines expanding and clinical development productivity improving, fueling sustained trial demand.
REGION
Asia Pacific to be fastest-growing region in global CRO services market during forecast period
The Asia Pacific CRO services market is expected to register the highest CAGR during the forecast period, driven by the growth in the pharmaceutical and biopharmaceutical industries, the low cost of conducting clinical trials in the region, the implementation of favorable government policies, and the rising number of CROs in the region.

contract-research-organization-service-market: COMPANY EVALUATION MATRIX
In the CRO services market matrix, IQVIA (Star) leads with commanding market share and global operational reach, supported by its advanced data analytics, technology-driven clinical trial solutions, and deep expertise serving top pharmaceutical and biotech sponsors. IQVIA’s integrated offerings and extensive global site network make it the preferred partner for large-scale, multi-regional clinical programs. Medpace (Emerging Leader) is rapidly gaining recognition for its specialized focus in specific therapeutic areas, hands-on project management, and high-touch service model tailored to emerging biotechs and mid-sized pharma clients. Through quality execution and niche expertise, Medpace continues to strengthen its competitive position and expand its footprint in key markets.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- IQVIA, Inc.
- ICON Plc.
- Thermo Fisher Scientific Inc.
- Fortrea
- Syneos Health
- Labcorp (US)
- Medpace
- WuXi AppTec
- Frontage Labs
- Pharmaron
- Tigermed
- SGS Société Générale De Surveillance SA.
- Eurofins Scientific
- Linical
- Parexel International Corporation
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 79.10 Billion |
| Market Forecast in 2030 (Value) | USD 125.95 Billion |
| Growth Rate | CAGR of 8.3% from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
WHAT IS IN IT FOR YOU: contract-research-organization-service-market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| CRO Services market analysis for FSP Model |
|
|
| Quantitative and qualitative analysis (regional level) |
|
|
| Partner identification in emerging economies |
|
|
RECENT DEVELOPMENTS
- August 2025 : IQVIA Inc. and Veeva Systems announced global clinical and commercial partnerships and resolved all pending legal disputes.
- March 2025 : ICON plc and Mural Health Technologies, Inc. partnered to utilize the participant management and payments platform named Mural Link.
- January 2024 : Thermo Fisher Scientific Inc. expanded its global laboratory services capability with a new bioanalytical lab in GoCo Health Innovation City in Gothenburg, Sweden, that serves pharmaceutical and biotech customers with advanced laboratory services and instrumentation across all phases of pharmaceutical development.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
- 5.1 INTRODUCTION
-
5.2 MARKET DYNAMICSDRIVERS- Rising clinical trial volume and escalating protocol complexity- Growing focus on decentralized/patient-centric trials- Increasing preference for service flexibility- Technological integration- Growing R&D budgets and expanding late-stage pipelinesOPPORTUNITIES- Shift toward regulatory compliance- Growing adoption of risk-based monitoring- Favorable reimbursement scenarioCHALLENGES- Patient retention- Cybersecurity and intellectual property challenges
-
6.1 MARKET TRENDSHEALTH ECONOMICS & OUTCOMES RESEARCH AND REAL-WORLD EVIDENCEIN-SILICO TRIALSSPECIALIZED ANALYTICS FOR EMERGING MODALITIES
- 6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
-
6.3 PRICING ANALYSISINDICATIVE PRICING ANALYSIS, BY SERVICE TYPEINDICATIVE PRICING ANALYSIS, BY PHASEINDICATIVE PRICING ANALYSIS, BY REGION
- 6.4 VALUE CHAIN ANALYSIS
- 6.5 ECOSYSTEM ANALYSIS
- 6.6 INVESTMENT/FUNDING ACTIVITY
-
6.7 TECHNOLOGY ANALYSISKEY TECHNOLOGIES- Clinical trial management system- Randomization and trial supply management- Electronic Data Capture (EDC) systemCOMPLEMENTARY TECHNOLOGIES- Model-informed drug development- Data management and informatics technologiesADJACENT TECHNOLOGIES- Clinical trial simulation tools
- 6.8 KEY CONFERENCES AND EVENTS
-
6.9 REGULATORY LANDSCAPEREGULATORY FRAMEWORK- North America- Europe- Asia Pacific- Rest of the WorldREGULATORY ANALYSISREGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONSREGULATORY SCENARIO FOR DRUG APPROVALS AND CGMP PROCEDURES
-
6.10 PORTER’S FIVE FORCES ANALYSISBARGAINING POWER OF SUPPLIERSBARGAINING POWER OF BUYERSTHREAT OF NEW ENTRANTSTHREAT OF SUBSTITUTESINTENSITY OF COMPETITIVE RIVALRY
-
6.11 KEY STAKEHOLDERS AND BUYING CRITERIAKEY STAKEHOLDERS IN BUYING PROCESSBUYING CRITERIA
-
6.12 CUSTOMER LANDSCAPEBUDGET ALLOCATION TRENDADOPTION BARRIER AND INTERNAL FRICTION
-
6.13 IMPACT OF AI/GEN AI ON CRO SERVICES MARKETINTRODUCTIONMARKET POTENTIAL ACROSS DRUG DEVELOPMENT STAGESAI USE CASESKEY COMPANIES IMPLEMENTING AIFUTURE OF GENERATIVE AI IN DRUG DEVELOPMENT ECOSYSTEM
-
6.14 IMPACT OF 2025 TRUMP TARIFF ON CRO SERVICES MARKETINTRODUCTIONKEY TARIFF RATESPRICE IMPACT ANALYSISIMPACT ON COUNTRY/REGION- North America (US)- Europe- Asia PacificIMPACT ON END-USE INDUSTRIES- Pharmaceutical & biotech companies- Medical device companies- Academic institutes
- 7.1 INTRODUCTION
-
7.2 CLINICAL RESEARCH SERVICESPHASE III- Large-scale testing ability to assess efficacy and safety of drugs to aid growthPHASE II- Growing number of pipeline products in Phase II studies to drive marketPHASE I- Robust pipeline of pharmaceutical and biopharmaceutical products to support growthPHASE IV- Stringent global regulations for drug safety monitoring to spur growth
-
7.3 EARLY PHASE DEVELOPMENT SERVICESCHEMISTRY, MANUFACTURING, AND CONTROL SERVICES- Growing need to meet regulatory norms for drugs to fuel marketPRECLINICAL SERVICES- Pharmacokinetics/Pharmacodynamics- Toxicology testing- Other preclinical servicesDISCOVERY STUDIES- Increasing reliance on CRO services for target identification and validation to expedite growth
-
7.4 LABORATORY SERVICESANALYTICAL TESTING- Physical characterization- Raw material testing- Batch-release testing- Stability testing- Other analytical testing servicesBIOANALYTICAL TESTING- Increasing outsourcing of R&D activities to accelerate growth
-
7.5 CONSULTING SERVICESGROWING ADOPTION OF CONSULTING SERVICES FOR FASTER REGULATORY APPROVALS TO BOOST MARKET
-
7.6 DATA MANAGEMENT SERVICESNEED TO TRACK PROGRESS OF EARLY DRUG DEVELOPMENT TO AUGMENT GROWTH
- 8.1 INTRODUCTION
-
8.2 ONCOLOGYBREAST CANCER- Increasing cases and high spending on treating breast cancer to support growthLUNG CANCER- Increasing focus on developing drugs against lung cancer to foster growthCOLORECTAL CANCER- Increasing drug discovery and development efforts against colorectal cancer to aid growthPROSTATE CANCER- Growing clinical pipeline to propel marketOTHER CANCERS
-
8.3 INFECTIOUS DISEASESINCREASING INCIDENCE OF CHRONIC INFECTIONS TO SUPPORT GROWTH
-
8.4 CARDIOVASCULAR SYSTEM DISORDERSHIGH MORTALITY RATES DUE TO CARDIOVASCULAR DISEASES TO FUEL MARKET
-
8.5 NEUROLOGYGROWING INVESTMENTS IN NEUROLOGICAL DISORDER RESEARCH TO DRIVE MARKET
-
8.6 VACCINESINCREASING FOCUS ON VACCINE DEVELOPMENT TO SPUR GROWTH
-
8.7 METABOLIC DISORDERS/ENDOCRINOLOGYINCREASING GLOBAL DIABETES AND OBESITY POPULATION TO PROMOTE GROWTH
-
8.8 IMMUNOLOGICAL DISORDERSGROWING CLINICAL RESEARCH FOR IMMUNOLOGICAL DISORDERS TO BOOST MARKET
-
8.9 PSYCHIATRYRISING CASES OF PSYCHIATRIC DISORDERS AND DEPRESSION TO SUSTAIN GROWTH
-
8.10 RESPIRATORY DISORDERSRISING INCIDENCE OF CHRONIC RESPIRATORY DISEASE TO FOSTER GROWTH
-
8.11 DERMATOLOGYGROWING FOCUS ON DRUG DEVELOPMENT AGAINST VARIOUS SKIN CONDITIONS TO DRIVE MARKET
-
8.12 OPHTHALMOLOGYGROWTH IN OPHTHALMOLOGY PIPELINE DRUGS TO SUPPORT MARKET
-
8.13 GASTROINTESTINAL DISEASESRAPID LIFESTYLE AND DIETARY CHANGES TO AMPLIFY GROWTH
-
8.14 GENITOURINARY & WOMEN’S HEALTHRISING AWARENESS ABOUT EARLY DISEASE DIAGNOSIS AND TREATMENT TO BOLSTER GROWTH
-
8.15 HEMATOLOGYINCREASING DRUG APPROVALS FOR DRUGS AGAINST NON-MALIGNANT HEMATOLOGICAL CONDITIONS TO SUPPORT GROWTH
- 8.16 OTHER THERAPEUTIC AREAS
- 9.1 INTRODUCTION
-
9.2 SMALL MOLECULESONGOING SURGE IN PHARMACEUTICAL R&D INVESTMENTS TO SUPPORT GROWTH
-
9.3 BIOLOGICSMONOCLONAL ANTIBODY- Surging demand for targeted therapies across oncology, autoimmune disorders, and infectious diseases to drive marketCELL & GENE THERAPY- Robust drug pipeline and R&D initiatives to drive marketOTHER BIOLOGICS
-
9.4 MEDICAL DEVICESRAPID INNOVATIONS IN DIAGNOSTICS, IMPLANTABLE, AND DIGITAL HEALTH TECHNOLOGIES TO FOSTER GROWTH
-
9.5 BIOSIMILARSMONOCLONAL ANTIBODY BIOSIMILARS- Rising demand for affordable therapeutic options to support growthINSULIN- Increasing patent expirations to contribute to growthCOLONY STIMULATING FACTOR- Increasing use of colony stimulating factor during post-chemotherapy to aid growthERYTHROPOEITIN- Essential role of erythropoietin in treating anemia to stimulate growthOTHER BIOSIMILARS
- 10.1 INTRODUCTION
-
10.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIESINCREASING OUTSOURCING AND PARTNERSHIPS TO ACCELERATE GROWTH
-
10.3 MEDICAL DEVICE COMPANIESINCREASING RECOGNITION OF CRO PROVIDERS TO AUGMENT GROWTH
-
10.4 ACADEMIC INSTITUTESCONSISTENT COLLABORATIONS BETWEEN CROS AND ACADEMIA TO INTENSIFY GROWTH
- 11.1 INTRODUCTION
-
11.2 NORTH AMERICAMACROECONOMIC OUTLOOK FOR NORTH AMERICAUS- Increasing incidence of oncology indications to accelerate growthCANADA- Favorable government initiatives and high investments to support growth
-
11.3 EUROPEMACROECONOMIC OUTLOOK FOR EUROPEGERMANY- Presence of strong pharmaceutical and biotechnology R&D infrastructure to spur growthUK- Rising R&D expenditure in pharmaceutical industry to expedite growthFRANCE- Increasing technological advancements and faster drug discovery and development initiatives to aid growthITALY- Short timeline for drug approvals to encourage growthSPAIN- Growing investment in pharmaceutical industry to boost marketREST OF EUROPE
-
11.4 ASIA PACIFICMACROECONOMIC OUTLOOK FOR ASIA PACIFICCHINA- Continued efforts on improving level of drug safety and supply to spur growthINDIA- Large pool of patients and presence of highly skilled medical professionals to augment growthJAPAN- Growing drug development activity to propel marketAUSTRALIA- Growing focus on funding opportunities to boost marketSOUTH KOREA- Emerging clinical research hub to sustain growthREST OF ASIA PACIFIC
-
11.5 LATIN AMERICAMACROECONOMIC OUTLOOK FOR LATIN AMERICABRAZIL- Growing focus on enhancing pharmaceutical research and production to fuel marketMEXICO- Increasing investments in pharma R&D to promote growthREST OF LATIN AMERICA
-
11.6 MIDDLE EASTMACROECONOMIC OUTLOOK FOR MIDDLE EASTGCC COUNTRIES- Kingdom of Saudi Arabia (KSA)- United Arab Emirates (UAE)- Rest of Middle East
-
11.7 AFRICABOOMING PHARMACEUTICAL INDUSTRY TO FACILITATE GROWTHMACROECONOMIC OUTLOOK FOR AFRICA
- 12.1 INTRODUCTION
-
12.2 KEY PLAYER STRATEGIES/RIGHT TO WINOVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CRO SERVICES MARKET
- 12.3 REVENUE ANALYSIS, 2020–2024
- 12.4 MARKET SHARE ANALYSIS, 2024
- 12.5 COMPANY VALUATION AND FINANCIAL METRICS
- 12.6 BRAND/SERVICE COMPARISON
-
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024STARSEMERGING LEADERSPERVASIVE PLAYERSPARTICIPANTSCOMPANY FOOTPRINT: KEY PLAYERS, 2024- Company footprint- Region footprint- Type footprint
-
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024PROGRESSIVE COMPANIESRESPONSIVE COMPANIESDYNAMIC COMPANIESSTARTING BLOCKSCOMPETITIVE BENCHMARKING- Detailed list of key startups/SMEs- Competitive benchmarking of key startups/SMEs
-
12.9 COMPETITIVE SCENARIOSERVICE/SOLUTION LAUNCHES AND APPROVALSDEALSEXPANSIONS
-
13.1 KEY PLAYERSIQVIA INC.- Business overview- Services/Solutions offered- Recent developments- MnM viewICON PLC- Business overview- Services/Solutions offered- Recent developments- MnM viewTHERMO FISHER SCIENTIFIC INC.- Business overview- Services/Solutions offered- Recent developments- MnM viewLABCORP- Business overview- Services/Solutions offered- Recent developments- MnM viewFORTREA, INC.- Company overview- Services/Solutions offered- Recent developments- MnM viewSYNEOS HEALTH- Business overview- Services/Solutions offered- Recent developmentsWUXI APPTEC- Business overview- Services/Solutions offered- Recent developmentsCHARLES RIVER LABORATORIES- Business overview- Services/Solutions offered- Recent developmentsPAREXEL INTERNATIONAL CORPORATION- Business overview- Services/Solutions offered- Recent developmentsPHARMARON- Business overview- Services/Solutions offeredMEDPACE- Business overview- Services/Solutions offeredSGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA- Business overview- Services/Solutions offered- Recent developmentsFRONTAGE LABS- Business overview- Services/Solutions offered- Recent developmentsEUROFINS SCIENTIFIC- Business overview- Services/Solutions offered- Recent developmentsTIGERMED- Business overview- Services/Solutions offered- Recent developmentsPSI- Business overview- Services/Solutions offered- Recent developmentsBIOAGILE THERAPEUTICS PRIVATE LIMITED- Business overview- Services/Solutions offeredFIRMA CLINICAL RESEARCH- Business overview- Services/Solutions offeredACCULAB LIFE SCIENCES- Business overview- Services/Solutions offeredNOVOTECH- Business overview- Services/Solutions offered- Recent developmentsLINICAL- Business overview- Services/Solutions offered- Recent developmentsADVANCED CLINICAL- Business overview- Services/Solutions offered- Recent developments
-
13.2 OTHER PLAYERSALLUCENTEMVENIOGUIRES INC.WORLDWIDE CLINICAL TRIALSCTI CLINICAL TRIAL & CONSULTING
- 14.1 DISCUSSION GUIDE
- 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- 14.3 CUSTOMIZATION OPTIONS
- 14.4 RELATED REPORTS
- 14.5 AUTHOR DETAILS
- TABLE 1 CRO SERVICES MARKET: INCLUSIONS AND EXCLUSIONS
- TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
- TABLE 3 CRO SERVICES MARKET: RISK ANALYSIS
- TABLE 4 CRO SERVICES MARKET: STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
- TABLE 5 CRO SERVICES MARKET: EMERGING BUSINESS MODELS AND TARGET SEGMENTS
- TABLE 6 CRO SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
- TABLE 7 INDICATIVE PRICING ANALYSIS, BY SERVICE TYPE, 2024 (USD)
- TABLE 8 INDICATIVE PRICING ANALYSIS, BY PHASE, 2024 (USD MILLION)
- TABLE 9 INDICATIVE PRICING ANALYSIS, BY REGION, 2024 (USD MILLION)
- TABLE 10 CRO SERVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
- TABLE 11 CRO SERVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
- TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 16 CRO SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
- TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY MODALITY
- TABLE 18 KEY BUYING CRITERIA, BY END USER
- TABLE 19 CRO SERVICES MARKET: ADOPTION BARRIER AND INTERNAL FRICTION
- TABLE 20 CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 21 NUMBER OF REGISTERED AND RECRUITING CLINICAL STUDIES AS OF AUGUST 2024, BY LOCATION
- TABLE 22 CLINICAL RESEARCH SERVICES OFFERED BY MARKET PLAYERS
- TABLE 23 CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 24 CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 25 NORTH AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 26 EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 27 ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 28 LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 29 MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 30 GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 31 CRO SERVICES MARKET FOR PHASE III, BY REGION, 2023–2030 (USD MILLION)
- TABLE 32 NORTH AMERICA: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 33 EUROPE: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 34 ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 35 LATIN AMERICA: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 36 MIDDLE EAST: CRO SERVICES MARKET FOR PHASE III, BY REGION, 2023–2030 (USD MILLION)
- TABLE 37 GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 38 CRO SERVICES MARKET FOR PHASE II, BY REGION, 2023–2030 (USD MILLION)
- TABLE 39 NORTH AMERICA: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 40 EUROPE: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 41 ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 42 LATIN AMERICA: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 43 MIDDLE EAST: CRO SERVICES MARKET FOR PHASE II, BY REGION, 2023–2030 (USD MILLION)
- TABLE 44 GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 45 CRO SERVICES MARKET FOR PHASE I, BY REGION, 2023–2030 (USD MILLION)
- TABLE 46 NORTH AMERICA: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 47 EUROPE: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 48 ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 49 LATIN AMERICA: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 50 MIDDLE EAST: CRO SERVICES MARKET FOR PHASE I, BY REGION, 2023–2030 (USD MILLION)
- TABLE 51 GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 52 CRO SERVICES MARKET FOR PHASE IV, BY REGION, 2023–2030 (USD MILLION)
- TABLE 53 NORTH AMERICA: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 54 EUROPE: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 55 ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 56 LATIN AMERICA: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 57 MIDDLE EAST: CRO SERVICES MARKET FOR PHASE IV, BY REGION, 2023–2030 (USD MILLION)
- TABLE 58 GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 59 CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 60 CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 61 NORTH AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 62 EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 63 ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 64 LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 65 MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 66 GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 67 CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 68 NORTH AMERICA: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 69 EUROPE: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 70 ASIA PACIFIC: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 71 LATIN AMERICA: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 72 MIDDLE EAST: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 73 GCC COUNTRIES: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 74 CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 75 CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 76 NORTH AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 77 EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 78 ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 79 LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 80 MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 81 GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 82 CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 83 NORTH AMERICA: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 84 EUROPE: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 85 ASIA PACIFIC: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 86 LATIN AMERICA: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 87 MIDDLE EAST: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 88 GCC COUNTRIES: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 89 CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 90 NORTH AMERICA: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 91 EUROPE: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 92 ASIA PACIFIC: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 93 LATIN AMERICA: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 94 MIDDLE EAST: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 95 GCC COUNTRIES: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 96 CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 97 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 98 EUROPE: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 99 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 100 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 101 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 102 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 103 CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 104 NORTH AMERICA: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 105 EUROPE: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 106 ASIA PACIFIC: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 107 LATIN AMERICA: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 108 MIDDLE EAST: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 109 GCC COUNTRIES: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 110 LABORATORY SERVICES OFFERED BY KEY PLAYERS
- TABLE 111 CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 112 CRO SERVICES MARKET FOR LABORATORY SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 113 NORTH AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 114 EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 115 ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 116 LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 117 MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 118 GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 119 CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 120 CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 121 NORTH AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 122 EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 123 ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 124 LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 125 MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 126 GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 127 CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY REGION, 2023–2030 (USD MILLION)
- TABLE 128 NORTH AMERICA: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 129 EUROPE: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 130 ASIA PACIFIC: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 131 LATIN AMERICA: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 132 MIDDLE EAST: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY REGION, 2023–2030 (USD MILLION)
- TABLE 133 GCC COUNTRIES: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 134 CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 135 NORTH AMERICA: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 136 EUROPE: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 137 ASIA PACIFIC: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 138 LATIN AMERICA: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 139 MIDDLE EAST: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 140 GCC COUNTRIES: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 141 CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 142 NORTH AMERICA: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 143 EUROPE: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 144 ASIA PACIFIC: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 145 LATIN AMERICA: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 146 MIDDLE EAST: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 147 GCC COUNTRIES: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 148 CRO SERVICES MARKET FOR STABILITY TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 149 NORTH AMERICA: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 150 EUROPE: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 151 ASIA PACIFIC: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 152 LATIN AMERICA: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 153 MIDDLE EAST: CRO SERVICES MARKET FOR STABILITY TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 154 GCC COUNTRIES: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 155 CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 156 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 157 EUROPE: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 158 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 159 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING,BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 160 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 161 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 162 CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 163 NORTH AMERICA: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 164 EUROPE: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 165 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 166 LATIN AMERICA: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 167 MIDDLE EAST: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
- TABLE 168 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 169 CONSULTING SERVICES OFFERED BY PROMINENT PLAYERS
- TABLE 170 CRO SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 171 NORTH AMERICA: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 172 EUROPE: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 173 ASIA PACIFIC: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 174 LATIN AMERICA: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 175 MIDDLE EAST: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 176 GCC COUNTRIES: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 177 CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 178 NORTH AMERICA: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 179 EUROPE: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 180 ASIA PACIFIC: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 181 LATIN AMERICA: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 182 MIDDLE EAST: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 183 GCC COUNTRIES: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 184 CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 185 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040
- TABLE 186 CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 187 CRO SERVICES MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 188 NORTH AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 189 EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 190 ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 191 LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 192 MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 193 GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 194 CRO SERVICES MARKET FOR BREAST CANCER, BY REGION, 2023–2030 (USD MILLION)
- TABLE 195 NORTH AMERICA: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 196 EUROPE: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 197 ASIA PACIFIC: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 198 LATIN AMERICA: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 199 MIDDLE EAST: CRO SERVICES MARKET FOR BREAST CANCER, BY REGION, 2023–2030 (USD MILLION)
- TABLE 200 GCC COUNTRIES: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 201 CRO SERVICES MARKET FOR LUNG CANCER, BY REGION, 2023–2030 (USD MILLION)
- TABLE 202 NORTH AMERICA: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 203 EUROPE: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 204 ASIA PACIFIC: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 205 LATIN AMERICA: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 206 MIDDLE EAST: CRO SERVICES MARKET FOR LUNG CANCER, BY REGION, 2023–2030 (USD MILLION)
- TABLE 207 GCC COUNTRIES: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 208 CRO SERVICES MARKET FOR COLORECTAL CANCER, BY REGION, 2023–2030 (USD MILLION)
- TABLE 209 NORTH AMERICA: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 210 EUROPE: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 211 ASIA PACIFIC: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 212 LATIN AMERICA: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 213 MIDDLE EAST: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY REGION, 2023–2030 (USD MILLION)
- TABLE 214 GCC COUNTRIES: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 215 CRO SERVICES MARKET FOR PROSTATE CANCER, BY REGION, 2023–2030 (USD MILLION)
- TABLE 216 NORTH AMERICA: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 217 EUROPE: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 218 ASIA PACIFIC: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 219 LATIN AMERICA: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 220 MIDDLE EAST: CRO SERVICES MARKET FOR PROSTATE CANCER, BY REGION, 2023–2030 (USD MILLION)
- TABLE 221 GCC COUNTRIES: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 222 NUMBER OF DRUGS IN R&D PIPELINE FOR OTHER CANCERS, 2023–2024
- TABLE 223 CRO SERVICES MARKET FOR OTHER CANCERS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 224 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 225 EUROPE: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 226 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 227 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 228 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER CANCERS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 229 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 230 CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 231 NORTH AMERICA: CRO SERVICES MARKET FOR INFECTIOUS DISEASES,BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 232 EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY INFECTIOUS DISEASES, 2023–2030 (USD MILLION)
- TABLE 233 ASIA PACIFIC: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 234 LATIN AMERICA: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 235 MIDDLE EAST: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 236 GCC COUNTRIES: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 237 CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 238 NORTH AMERICA: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 239 EUROPE: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 240 ASIA PACIFIC: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 241 LATIN AMERICA: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 242 MIDDLE EAST: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 243 GCC COUNTRIES: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 244 CRO SERVICES MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 245 NORTH AMERICA: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 246 EUROPE: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 247 ASIA PACIFIC: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 248 LATIN AMERICA: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 249 MIDDLE EAST: CRO SERVICES MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 250 GCC COUNTRIES: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 251 CRO SERVICES MARKET FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 252 NORTH AMERICA: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 253 EUROPE: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 254 ASIA PACIFIC: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 255 LATIN AMERICA: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 256 MIDDLE EAST: CRO SERVICES MARKET FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 257 GCC COUNTRIES: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 258 CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 259 NORTH AMERICA: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 260 EUROPE: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 261 ASIA PACIFIC: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 262 LATIN AMERICA: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 263 MIDDLE EAST: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 264 GCC COUNTRIES: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 265 CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 266 NORTH AMERICA: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 267 EUROPE: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 268 ASIA PACIFIC: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 269 LATIN AMERICA: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 270 MIDDLE EAST: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 271 GCC COUNTRIES: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 272 CRO SERVICES MARKET FOR PSYCHIATRY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 273 NORTH AMERICA: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 274 EUROPE: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 275 ASIA PACIFIC: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 276 LATIN AMERICA: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 277 MIDDLE EAST: CRO SERVICES MARKET FOR PSYCHIATRY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 278 GCC COUNTRIES: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 279 CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 280 NORTH AMERICA: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 281 EUROPE: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 282 ASIA PACIFIC: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 283 LATIN AMERICA: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 284 MIDDLE EAST: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 285 GCC COUNTRIES: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 286 CRO SERVICES MARKET FOR DERMATOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 287 NORTH AMERICA: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 288 EUROPE: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 289 ASIA PACIFIC: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 290 LATIN AMERICA: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 291 MIDDLE EAST: CRO SERVICES MARKET FOR DERMATOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 292 GCC COUNTRIES: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 293 CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 294 NORTH AMERICA: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 295 EUROPE: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 296 ASIA PACIFIC: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 297 LATIN AMERICA: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 298 MIDDLE EAST: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 299 GCC COUNTRIES: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 300 CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 301 NORTH AMERICA: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 302 EUROPE: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 303 ASIA PACIFIC: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 304 LATIN AMERICA: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 305 MIDDLE EAST: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 306 GCC COUNTRIES: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 307 CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY REGION, 2023–2030 (USD MILLION)
- TABLE 308 NORTH AMERICA: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 309 EUROPE: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH,BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 310 ASIA PACIFIC: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 311 LATIN AMERICA: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 312 MIDDLE EAST: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY REGION, 2023–2030 (USD MILLION)
- TABLE 313 GCC COUNTRIES: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 314 CRO SERVICES MARKET FOR HEMATOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 315 NORTH AMERICA: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 316 EUROPE: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 317 ASIA PACIFIC: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 318 LATIN AMERICA: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 319 MIDDLE EAST: CRO SERVICES MARKET FOR HEMATOLOGY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 320 GCC COUNTRIES: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 321 CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 322 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 323 EUROPE: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 324 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 325 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 326 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 327 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 328 CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 329 CRO SERVICES MARKET FOR SMALL MOLECULES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 330 NORTH AMERICA: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 331 EUROPE: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 332 ASIA PACIFIC: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 333 LATIN AMERICA: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 334 MIDDLE EAST: CRO SERVICES MARKET FOR SMALL MOLECULES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 335 GCC COUNTRIES: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 336 CRO SERVICES MARKET FOR BIOLOGICS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 337 NORTH AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 338 EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 339 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 340 LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 341 MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 342 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 343 CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 344 CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 345 NORTH AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 346 EUROPE: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 347 ASIA PACIFIC: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 348 LATIN AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 349 MIDDLE EAST: CRO SERVICES BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 350 GCC COUNTRIES: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 351 CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 352 NORTH AMERICA: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 353 EUROPE: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 354 ASIA PACIFIC: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 355 LATIN AMERICA: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 356 MIDDLE EAST: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
- TABLE 357 GCC COUNTRIES: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 358 CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 359 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 360 EUROPE: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 361 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 362 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 363 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 364 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 365 CRO SERVICES MARKET FOR MEDICAL DEVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 366 NORTH AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 367 EUROPE: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 368 ASIA PACIFIC: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 369 LATIN AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 370 MIDDLE EAST: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 371 GCC COUNTRIES: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 372 CRO SERVICES MARKET FOR BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 373 NORTH AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 374 EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 375 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 376 LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 377 MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 378 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 379 CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 380 CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 381 NORTH AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 382 EUROPE: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 383 ASIA PACIFIC: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 384 LATIN AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 385 MIDDLE EAST: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 386 GCC COUNTRIES: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 387 CRO SERVICES MARKET FOR INSULIN, BY REGION, 2023–2030 (USD MILLION)
- TABLE 388 NORTH AMERICA: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 389 EUROPE: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 390 ASIA PACIFIC: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 391 LATIN AMERICA: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 392 MIDDLE EAST: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 393 GCC COUNTRIES: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 394 CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY REGION, 2023–2030 (USD MILLION)
- TABLE 395 NORTH AMERICA: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 396 EUROPE: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 397 ASIA PACIFIC: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 398 LATIN AMERICA: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 399 MIDDLE EAST: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY REGION, 2023–2030 (USD MILLION)
- TABLE 400 GCC COUNTRIES: CRO SERVICES BIOSIMILARS MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 401 CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY REGION, 2023–2030 (USD MILLION)
- TABLE 402 NORTH AMERICA: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 403 EUROPE: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 404 ASIA PACIFIC: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 405 LATIN AMERICA: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 406 MIDDLE EAST: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY REGION, 2023–2030 (USD MILLION)
- TABLE 407 GCC COUNTRIES: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 408 CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 409 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 410 EUROPE: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY,2023–2030 (USD MILLION)
- TABLE 411 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 412 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 413 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
- TABLE 414 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 415 CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 416 CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 417 NORTH AMERICA: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 418 EUROPE: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 419 ASIA PACIFIC: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 420 LATIN AMERICA: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 421 MIDDLE EAST: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 422 GCC COUNTRIES: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 423 CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 424 NORTH AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 425 EUROPE: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 426 ASIA PACIFIC: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 427 LATIN AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 428 MIDDLE EAST: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 429 GCC COUNTRIES: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 430 CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 431 NORTH AMERICA: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 432 EUROPE: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 433 ASIA PACIFIC: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 434 LATIN AMERICA: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 435 MIDDLE EAST: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
- TABLE 436 GCC COUNTRIES: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 437 CRO SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
- TABLE 438 NORTH AMERICA: CRO SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 439 NORTH AMERICA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 440 NORTH AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES,BY PHASE, 2023–2030 (USD MILLION)
- TABLE 441 NORTH AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 442 NORTH AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 443 NORTH AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 444 NORTH AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 445 NORTH AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 446 NORTH AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 447 NORTH AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 448 NORTH AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 449 NORTH AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 450 NORTH AMERICA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 451 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
- TABLE 452 US: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 453 US: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 454 US: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 455 US: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 456 US: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 457 US: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 458 US: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 459 US: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 460 US: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 461 US: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 462 US: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 463 US: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 464 CANADA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 465 CANADA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 466 CANADA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 467 CANADA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 468 CANADA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 469 CANADA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 470 CANADA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 471 CANADA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 472 CANADA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 473 CANADA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 474 CANADA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 475 CANADA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 476 EUROPE: CRO SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 477 EUROPE: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 478 EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 479 EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 480 EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 481 EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 482 EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 483 EUROPE: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 484 EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 485 EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 486 EUROPE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 487 EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 488 EUROPE: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 489 EUROPE: KEY MACROECONOMIC INDICATORS
- TABLE 490 GERMANY: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 491 GERMANY: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 492 GERMANY: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 493 GERMANY: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 494 GERMANY: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 495 GERMANY: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 496 GERMANY: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 497 GERMANY: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 498 GERMANY: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 499 GERMANY: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 500 GERMANY: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 501 GERMANY: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 502 UK: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 503 UK: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 504 UK: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 505 UK: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 506 UK: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 507 UK: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 508 UK: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 509 UK: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 510 UK: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 511 UK: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 512 UK: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 513 UK: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 514 FRANCE: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 515 FRANCE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 516 FRANCE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 517 FRANCE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 518 FRANCE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 519 FRANCE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 520 FRANCE: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 521 FRANCE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 522 FRANCE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 523 FRANCE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 524 FRANCE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 525 FRANCE: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 526 ITALY: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 527 ITALY: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 528 ITALY: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 529 ITALY: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 530 ITALY: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 531 ITALY: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 532 ITALY: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 533 ITALY: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 534 ITALY: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 535 ITALY: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 536 ITALY: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 537 ITALY: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 538 SPAIN: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 539 SPAIN: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 540 SPAIN: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 541 SPAIN: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 542 SPAIN: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 543 SPAIN: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 544 SPAIN: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 545 SPAIN: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 546 SPAIN: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 547 SPAIN: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 548 SPAIN: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 549 SPAIN: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 550 REST OF EUROPE: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 551 REST OF EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 552 REST OF EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 553 REST OF EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 554 REST OF EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 555 REST OF EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 556 REST OF EUROPE: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 557 REST OF EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 558 REST OF EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 559 REST OF EUROPE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 560 REST OF EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 561 REST OF EUROPE: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 562 ASIA PACIFIC: CRO SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 563 ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 564 ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 565 ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 566 ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 567 ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 568 ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 569 ASIA PACIFIC: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 570 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 571 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 572 ASIA PACIFIC: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 573 ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 574 ASIA PACIFIC: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 575 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
- TABLE 576 CHINA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 577 CHINA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 578 CHINA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 579 CHINA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 580 CHINA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 581 CHINA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 582 CHINA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 583 CHINA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 584 CHINA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 585 CHINA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 586 CHINA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 587 CHINA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 588 INDIA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 589 INDIA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 590 INDIA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 591 INDIA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 592 INDIA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 593 INDIA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 594 INDIA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 595 INDIA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 596 INDIA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 597 INDIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 598 INDIA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 599 INDIA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 600 JAPAN: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 601 JAPAN: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 602 JAPAN: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 603 JAPAN: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 604 JAPAN: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 605 JAPAN: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 606 JAPAN: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 607 JAPAN: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 608 JAPAN: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 609 JAPAN: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 610 JAPAN: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 611 JAPAN: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 612 AUSTRALIA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 613 AUSTRALIA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 614 AUSTRALIA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 615 AUSTRALIA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 616 AUSTRALIA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 617 AUSTRALIA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 618 AUSTRALIA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 619 AUSTRALIA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 620 AUSTRALIA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 621 AUSTRALIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 622 AUSTRALIA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 623 AUSTRALIA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 624 SOUTH KOREA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 625 SOUTH KOREA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 626 SOUTH KOREA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 627 SOUTH KOREA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 628 SOUTH KOREA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 629 SOUTH KOREA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 630 SOUTH KOREA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 631 SOUTH KOREA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 632 SOUTH KOREA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 633 SOUTH KOREA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 634 SOUTH KOREA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 635 SOUTH KOREA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 636 REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 637 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 638 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 639 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 640 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES,BY TYPE, 2023–2030 (USD MILLION)
- TABLE 641 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 642 REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 643 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 644 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 645 REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 646 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 647 REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 648 LATIN AMERICA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 649 LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 650 LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 651 LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 652 LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 653 LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 654 LATIN AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 655 LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 656 LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 657 LATIN AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 658 LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 659 LATIN AMERICA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 660 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
- TABLE 661 BRAZIL: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 662 BRAZIL: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 663 BRAZIL: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 664 BRAZIL: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 665 BRAZIL: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 666 BRAZIL: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 667 BRAZIL: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 668 BRAZIL: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 669 BRAZIL: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 670 BRAZIL: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 671 BRAZIL: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE,2023–2030 (USD MILLION)
- TABLE 672 BRAZIL: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 673 MEXICO: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 674 MEXICO: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 675 MEXICO: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 676 MEXICO: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 677 MEXICO: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 678 MEXICO: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 679 MEXICO: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 680 MEXICO: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 681 MEXICO: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 682 MEXICO: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 683 MEXICO: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 684 MEXICO: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 685 REST OF LATIN AMERICA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 686 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 687 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 688 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 689 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 690 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 691 REST OF LATIN AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 692 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 693 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 694 REST OF LATIN AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 695 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 696 REST OF LATIN AMERICA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 697 MIDDLE EAST: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 698 MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES,BY PHASE, 2023–2030 (USD MILLION)
- TABLE 699 MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 700 MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 701 MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 702 MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 703 MIDDLE EAST: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 704 MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 705 MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 706 MIDDLE EAST: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 707 MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 708 MIDDLE EAST: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 709 MIDDLE EAST: KEY MACROECONOMIC INDICATORS
- TABLE 710 GCC COUNTRIES: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 711 GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 712 GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 713 GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 714 GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 715 GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 716 GCC COUNTRIES: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 717 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 718 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 719 GCC COUNTRIES: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 720 GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 721 GCC COUNTRIES: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 722 GCC COUNTRIES: CRO SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
- TABLE 723 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 724 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 725 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 726 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 727 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 728 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 729 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 730 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 731 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 732 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 733 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 734 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 735 UAE: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 736 UAE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 737 UAE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 738 UAE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 739 UAE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 740 UAE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 741 UAE: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 742 UAE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 743 UAE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 744 UAE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 745 UAE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 746 UAE: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 747 REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 748 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 749 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 750 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 751 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 752 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 753 REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 754 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 755 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 756 REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 757 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 758 REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 759 REST OF MIDDLE EAST: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 760 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 761 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 762 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 763 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 764 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 765 REST OF MIDDLE EAST: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 766 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 767 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 768 REST OF MIDDLE EAST: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 769 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 770 REST OF MIDDLE EAST: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 771 AFRICA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 772 AFRICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
- TABLE 773 AFRICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 774 AFRICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 775 AFRICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 776 AFRICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 777 AFRICA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
- TABLE 778 AFRICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 779 AFRICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 780 AFRICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
- TABLE 781 AFRICA: CRO SERVICES MARKET FOR ONCOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
- TABLE 782 AFRICA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
- TABLE 783 AFRICA: KEY MACROECONOMIC INDICATORS
- TABLE 784 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CRO SERVICES MARKET, JANUARY 2021–AUGUST 2025
- TABLE 785 CRO SERVICES MARKET: DEGREE OF COMPETITION
- TABLE 786 CRO SERVICES MARKET: REGION FOOTPRINT
- TABLE 787 CRO SERVICES MARKET: TYPE FOOTPRINT
- TABLE 788 CRO SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 789 CRO SERVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
- TABLE 790 CRO SERVICES MARKET: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 791 CRO SERVICES MARKET: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 792 CRO SERVICES MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 793 IQVIA INC.: COMPANY OVERVIEW
- TABLE 794 IQVIA INC.: SERVICES/SOLUTIONS OFFERED
- TABLE 795 IQVIA INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 796 IQVIA INC.: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 797 IQVIA INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025
- TABLE 798 ICON PLC: COMPANY OVERVIEW
- TABLE 799 ICON PLC: SERVICES/SOLUTIONS OFFERED
- TABLE 800 ICON PLC: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 801 ICON PLC: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 802 ICON PLC: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 803 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 804 THERMO FISHER SCIENTIFIC INC.: SERVICES/SOLUTIONS OFFERED
- TABLE 805 THERMO FISHER SCIENTIFIC, INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 806 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 807 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 808 LABCORP: COMPANY OVERVIEW
- TABLE 809 LABCORP: SERVICES/SOLUTIONS OFFERED
- TABLE 810 LABCORP: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 811 LABCORP: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 812 LABCORP: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 813 LABCORP: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025
- TABLE 814 FORTREA, INC.: COMPANY OVERVIEW
- TABLE 815 FORTREA, INC.: SERVICES/SOLUTIONS OFFERED
- TABLE 816 FORTREA, INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 817 FORTREA, INC.: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 818 FORTREA, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 819 FORTREA, INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025
- TABLE 820 SYNEOS HEALTH: COMPANY OVERVIEW
- TABLE 821 SYNEOS HEALTH: SERVICES/SOLUTIONS OFFERED
- TABLE 822 SYNEOS HEALTH: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 823 SYNEOS HEALTH: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 824 WUXI APPTEC: COMPANY OVERVIEW
- TABLE 825 WUXI APPTEC: SERVICES/SOLUTIONS OFFERED
- TABLE 826 WUXI APPTEC: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 827 WUXI APPTEC: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 828 WUXI APPTEC: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 829 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
- TABLE 830 CHARLES RIVER LABORATORIES: SERVICES/SOLUTIONS OFFERED
- TABLE 831 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 832 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 833 PAREXEL INTERNATIONAL CORPORATION: COMPANY OVERVIEW
- TABLE 834 PAREXEL INTERNATIONAL CORPORATION: SERVICES/SOLUTIONS OFFERED
- TABLE 835 PAREXEL INTERNATIONAL CORPORATION: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 836 PAREXEL INTERNATIONAL CORPORATION: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 837 PAREXEL INTERNATIONAL CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 838 PHARMARON: COMPANY OVERVIEW
- TABLE 839 PHARMARON: SERVICES/SOLUTIONS OFFERED
- TABLE 840 MEDPACE: COMPANY OVERVIEW
- TABLE 841 MEDPACE: SERVICES/SOLUTIONS OFFERED
- TABLE 842 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA: COMPANY OVERVIEW
- TABLE 843 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA: SERVICES/SOLUTIONS OFFERED
- TABLE 844 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 845 FRONTAGE LABS: COMPANY OVERVIEW
- TABLE 846 FRONTAGE LABS: SERVICES/SOLUTIONS OFFERED
- TABLE 847 FRONTAGE LABS: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 848 FRONTAGE LABS: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 849 FRONTAGE LABS: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025
- TABLE 850 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
- TABLE 851 EUROFINS SCIENTIFIC: SERVICES/SOLUTIONS OFFERED
- TABLE 852 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 853 TIGERMED: COMPANY OVERVIEW
- TABLE 854 TIGERMED: SERVICES/SOLUTIONS OFFERED
- TABLE 855 TIGERMED: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 856 TIGERMED: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 857 PSI: COMPANY OVERVIEW
- TABLE 858 PSI: SERVICES/SOLUTIONS OFFERED
- TABLE 859 PSI: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
- TABLE 860 PSI: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 861 PSI: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 862 BIOAGILE: COMPANY OVERVIEW
- TABLE 863 BIOAGILE: SERVICES/SOLUTIONS OFFERED
- TABLE 864 FIRMA CLINICAL RESEARCH: COMPANY OVERVIEW
- TABLE 865 FIRMA CLINICAL RESEARCH: SERVICES/SOLUTIONS OFFERED
- TABLE 866 ACCULAB LIFE SCIENCES: COMPANY OVERVIEW
- TABLE 867 ACCULAB LIFE SCIENCES: SERVICES/SOLUTIONS OFFERED
- TABLE 868 NOVOTECH: COMPANY OVERVIEW
- TABLE 869 NOVOTECH: SERVICES/SOLUTIONS OFFERED
- TABLE 870 NOVOTECH: DEALS, JANUARY 2021–JULY 2025
- TABLE 871 LINICAL: COMPANY OVERVIEW
- TABLE 872 LINICAL: SERVICES/SOLUTIONS OFFERED
- TABLE 873 LINICAL: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 874 LINICAL: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 875 ADVANCED CLINICAL: COMPANY OVERVIEW
- TABLE 876 ADVANCED CLINICAL: SERVICES/SOLUTIONS OFFERED
- TABLE 877 ADVANCED CLINICAL: DEALS, JANUARY 2021–AUGUST 2025
- TABLE 878 ADVANCED CLINICAL: EXPANSIONS, JANUARY 2021–AUGUST 2025
- TABLE 879 ALLUCENT: COMPANY OVERVIEW
- TABLE 880 EMVENIO: COMPANY OVERVIEW
- TABLE 881 GUIRES INC.: COMPANY OVERVIEW
- TABLE 882 WORLDWIDE CLINICAL TRIALS: COMPANY OVERVIEW
- TABLE 883 CTI CLINICAL TRIAL & CONSULTING: COMPANY OVERVIEW
- FIGURE 1 CRO SERVICES MARKET SEGMENTATION AND REGIONAL SCOPE
- FIGURE 2 CRO SERVICES MARKET: RESEARCH DESIGN
- FIGURE 3 CRO SERVICES MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
- FIGURE 4 GLOBAL CRO SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
- FIGURE 5 GLOBAL CRO SERVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
- FIGURE 6 ILLUSTRATIVE EXAMPLE OF IQVIA INC.: REVENUE SHARE ANALYSIS, 2024
- FIGURE 7 CRO SERVICES MARKET SIZE VALIDATION FROM PRIMARY SOURCES
- FIGURE 8 CRO SERVICES MARKET: SUPPLY-SIDE AND DEMAND-SIDE ANALYSIS AND TRIANGULATION
- FIGURE 9 CRO SERVICES MARKET: DEMAND-SIDE ANALYSIS, 2024
- FIGURE 10 TOP-DOWN APPROACH
- FIGURE 11 GLOBAL CRO SERVICES MARKET: CAGR PROJECTIONS, 2025–2030
- FIGURE 12 CRO SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
- FIGURE 13 CRO SERVICES MARKET: DATA TRIANGULATION METHODOLOGY
- FIGURE 14 CRO SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
- FIGURE 15 CRO SERVICES MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)
- FIGURE 16 CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2025 VS. 2030 (USD MILLION)
- FIGURE 17 CRO SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
- FIGURE 18 REGIONAL SNAPSHOT OF CRO SERVICES MARKET
- FIGURE 19 INCREASING CLINICAL PIPELINE AND RISING TRIAL VOLUME TO DRIVE MARKET
- FIGURE 20 US AND SMALL MOLECULES SEGMENT LED NORTH AMERICAN MARKET IN 2024
- FIGURE 21 CLINICAL RESEARCH SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024
- FIGURE 22 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT DOMINATED MARKET IN 2024
- FIGURE 23 CHINA TO REGISTER HIGHER CAGR DURING FORECAST PERIOD
- FIGURE 24 CRO SERVICES MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 25 ACTIVE PHARMACEUTICAL PIPELINE, 2013–2024
- FIGURE 26 REVENUE SHIFT AND NEW REVENUE POCKETS FOR CRO SERVICES MARKET
- FIGURE 27 INDICATIVE PRICING ANALYSIS, BY REGION, 2024 (USD MILLION)
- FIGURE 28 CRO SERVICES MARKET: VALUE CHAIN ANALYSIS
- FIGURE 29 CRO SERVICES MARKET: ECOSYSTEM ANALYSIS
- FIGURE 30 CRO SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
- FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY MODALITY
- FIGURE 32 KEY BUYING CRITERIA, BY END USER
- FIGURE 33 DRUGS IN PIPELINE, BY DEVELOPMENT PHASE, 2023 VS. 2024
- FIGURE 34 PROPORTION OF PIPELINE IN DEVELOPMENT FOR CANCER, 2013–2024
- FIGURE 35 ESTIMATED NUMBER OF INDIVIDUALS WITH DIABETES, 2000–2045 (MILLION)
- FIGURE 36 ANNUAL DRUG APPROVALS BY CENTER FOR DRUG EVALUATION ANDRESEARCH (FDA), 2012–2024
- FIGURE 37 R&D SPENDING OF PHRMA MEMBER COMPANIES, 2012–2023
- FIGURE 38 US FDA DE NOVO MEDICAL DEVICE APPROVALS, 2012–2024
- FIGURE 39 NORTH AMERICA: CRO SERVICES MARKET SNAPSHOT
- FIGURE 40 GLOBAL DISTRIBUTION OF R&D COMPANIES, JANUARY 2024 VS. JANUARY 2025
- FIGURE 41 ASIA PACIFIC: CRO SERVICES MARKET SNAPSHOT
- FIGURE 42 CRO SERVICES MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024
- FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CRO SERVICES MARKET, 2024
- FIGURE 44 EV/EBITDA OF KEY VENDORS
- FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCKBETA OF KEY VENDORS
- FIGURE 46 CRO SERVICES MARKET: BRAND/SERVICE COMPARISON
- FIGURE 47 CRO SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
- FIGURE 48 CRO SERVICES MARKET: COMPANY FOOTPRINT
- FIGURE 49 CRO SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
- FIGURE 50 IQVIA INC.: COMPANY SNAPSHOT (2024)
- FIGURE 51 ICON PLC: COMPANY SNAPSHOT (2024)
- FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
- FIGURE 53 LABCORP: COMPANY SNAPSHOT (2024)
- FIGURE 54 FORTREA, INC.: COMPANY SNAPSHOT (2024)
- FIGURE 55 WUXI APPTEC: COMPANY SNAPSHOT (2024)
- FIGURE 56 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
- FIGURE 57 PHARMARON: COMPANY SNAPSHOT (2024)
- FIGURE 58 MEDPACE: COMPANY SNAPSHOT (2024)
- FIGURE 59 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA: COMPANY SNAPSHOT (2024)
- FIGURE 60 FRONTAGE LABS: COMPANY SNAPSHOT (2024)
- FIGURE 61 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
- FIGURE 62 TIGERMED: COMPANY SNAPSHOT (2024)
Methodology
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global CRO services market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The market for companies offering CRO services is arrived at by secondary data available through paid and unpaid sources, analyzing the service portfolios of the leading companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify & collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from market & technology-oriented perspectives. Secondary data was analyzed to arrive at the overall size of the global CRO services market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global CRO services market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and medical device companies, and experts from the supply side, such as C-level and D-level executives, and trial managers. These interviews were conducted across regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (including Latin America, the Middle East, and Africa). This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews. In the complete market engineering process, the top-down & bottom-up approaches were extensively used, along with several data triangulation methods, to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down & bottom-up approaches were used to estimate and validate the total size of the CRO services market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Bottom-up & Top-down Approach
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process.

Data Triangulation
After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
CROs outsource research services to several pharmaceutical & biotechnology companies, medical device companies, and academic institutes. These services include clinical research, early-phase development, laboratory, consulting, and data management services. A sponsor (i.e., a company investigating the safety and efficacy of new drugs, therapies, or medical devices) partners with a CRO on a contractual or project-by-project basis. The CRO provides advice & guidance for planning, designing, and executing clinical trials; it offers a comprehensive and diverse range of services for each trial phase.
Stakeholders
- Contract Research Organizations (CROs)
- Clinical Trial Service Providers
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Manufacturing Companies
- Academic & Research Institutes
- Venture Capitalists & Investors
- Market Research & Consulting Firms
- Government Associations
- Medical Institutions & Universities
Report Objectives
- To define, describe, and forecast the CRO services market based on service type, therapeutic area, modality, end users, and region
- To provide detailed information regarding the primary factors influencing market growth, such as drivers, restraints, opportunities, and challenges
- To strategically analyze the micromarkets concerning individual growth trends, prospects, and contributions to the overall CRO services market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To analyze subsegments of the market concerning individual growth trends, prospects, and contributions to the overall market
- To forecast the revenue of the market segments concerning six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America, the Middle East (GCC and Rest of Middle East), and Africa.
- To profile the key market players and comprehensively analyze their market shares and core competencies
- To track & analyze competitive developments such as service launches, agreements, partnerships, acquisitions, business expansions, and research & development activities in the CRO services market.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Contract Research Organization (CRO) Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationGrowth opportunities and latent adjacency in Contract Research Organization (CRO) Services Market
James
Jun, 2022
Which are the driving factors of the contract research organization services market?.
John
Jun, 2022
Who are the major players operating in the contract research organization services market?.
Kahlill
Jun, 2022
Which region will lead the global contract research organization services market?.